|
The fast paced world of
preClinical drug development must
handle an ever increasing number of compounds
as discovery techniques benefit from new
technologies. Find out how 3C Company
helped this organization complete a Business
Process Reengineering effort encompassing the
areas of drug metabolism & pharmacokinetics,
toxicology and clinical pathology as candidate
compounds are identified for further Clinical
development.
|
| | |